MedTrace Logo

What Are the Determinant Factors of Ceasing Anti-seizure Medication in Infants With Neonatal Seizures?

NCT06211192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158

Last updated 2024-01-18

No results posted yet for this study

Summary

The investigators aimed to determine the factors for ceasing anti-seizure medication in infants who experienced seizures during the neonatal period. This retrospective, single-center, descriptive study was conducted in Balıkesir between December 2020 and February 2023, and 157 neonates were recruited.

Conditions

  • Neonatal Seizure

Interventions

OTHER

retrospective data collection

retrospective data collecting from medical records

Sponsors & Collaborators

  • Balikesir University

    lead OTHER

Principal Investigators

  • Mustafa Kösecik, Prof · Balikesir Üniversite Medical faculty hospital

Eligibility

Min Age
1 Hour
Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-11-01
Completion
2023-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06211192 on ClinicalTrials.gov